Navigation Links
Pathfinder and InnerOptic Announce Technology Integration to Enhance Visualization and Outcomes in Liver Surgery
Date:3/6/2013

NASHVILLE, Tenn. and HILLSBOROUGH, N.C., March 6, 2013 /PRNewswire-iReach/ -- Pathfinder Technologies, the developer of computer-assisted navigation products, and InnerOptic Technology, the developer of ultrasound-guided navigation products, announced a licensing agreement today that will enable Pathfinder to offer InnerOptic's technology on its Explorer™ navigation system.

In use at top cancer centers in the US, Pathfinder's Explorer™ system was designed to improve visualization in liver surgery by offering real-time instrument tracking in relation to 3D anatomical models built from pre-operative MRI or CT scans. InnerOptic's technology allows real-time, 3D visualization of a surgical instrument's location in the context of intra-operative ultrasound imaging, the standard imaging modality used in liver surgery today.

By adding InnerOptic's capabilities, Pathfinder provides the best technology in real-time tracking, in relation to both pre- and intra-operative imaging, offering physicians the most detailed and accurate anatomical information possible at the point of therapeutic delivery. Furthermore, Pathfinder will offer InnerOptic's electromagnetic navigation modality, which enables more precise tracking of the tip of a non-rigid surgical instrument, such as an ablation needle. In offering both electromagnetic and optical navigation modalities, Pathfinder can offer the most comprehensive navigation system on the market.

Pathfinder CEO Jim Cloar recognized this marriage of technologies as a critical step in offering physicians even greater visualization tools for enhanced outcomes. "Since its inception, our technology has improved safety and outcomes by offering real-time navigation from detailed pre-operative scans," noted Mr. Cloar. "However, incorporating InnerOptic's advanced ultrasound and electromagnetic tracking capabilities into our device enables even greater visualization and spatial accuracy. We are thrilled to integrate this technology into our product offering, because we know it will benefit patients."

Similarly, InnerOptic CEO Brian Heaney recognizes the significance of implementing real-time ultrasound tracking into the capabilities of Pathfinder's Explorer™ device. "We are excited to partner with Pathfinder Technologies to integrate our 3D navigation technology on Explorer™," said Mr. Heaney. "Combining our products onto one platform provides surgeons with multiple navigation solutions in performing complex liver interventions and, most importantly, enhancing patient outcomes."

Pathfinder Technologies has also officially changed its name from Pathfinder Therapeutics and re-launched its brand and website (www.pathnav.com). The purpose of these efforts is to highlight Pathfinder's plans to be holistically focused on the widespread use of navigation technology and visualization tools for surgical and interventional procedures. 

For more information on the integrating between Pathfinder and InnerOptic, contact Jim Cloar at jimc@pathnav.com or Brian Heaney at brian@inneroptic.com.

About Pathfinder Technologies
Pathfinder Technologies offers state-of-the-art computer-assisted navigation and 3D visualization for medical professionals, to enable more accurate and efficient delivery of cancer therapeutics in soft-tissue organs. Pathfinder's Scout™ visualization software enables precise surgical planning and volumetric analysis for soft-tissue abdominal procedures, allowing physicians to determine the optimal path of therapeutic delivery. Pathfinder's Explorer™ navigation system is the first medical device cleared by the FDA in the category of intraoperative soft-tissue tracking for open liver procedures. With the ability to track rigid therapeutic delivery instruments to within a few millimeters, Explorer™ offers a greater degree of precision to abdominal resections, ablations, and other procedures. For more information, please visit www.pathnav.com.

About InnerOptic Technology, Inc.
InnerOptic was founded in 2003 to commercialize the patented medical visualization technology developed by researchers at the University of North Carolina at Chapel Hill. InnerOptic is revolutionizing image-guided procedures with its InnerOptic's AIM™, a "GPS" that  improves a  physician's ability to accurately perform complex  minimally invasive procedures with ultrasound imaging. A privately held company, InnerOptic is headquartered in Hillsborough, NC. For more information, please visit www.inneroptic.com.



Media Contact: Jim Cloar Pathfinder Technologies, (615) 783-0094, jimc@pathnav.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Pathfinder Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HUYA Bioscience Announces Partnership With Shanghai Zhangjiang Biotech Pharmaceutical Base
2. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
3. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Impax Laboratories Inc.
4. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
5. DMH International Announces The Launch of TouchPACS
6. Elsevier and the American College of Cardiology Announce the Launch of a New Journal JACC: Heart Failure
7. Psyche Systems Announces Availability of Toxicology LIS
8. Jazz Pharmaceuticals Announces Pricing Of Public Offering Of Ordinary Shares By Selling Shareholders
9. DDS Lab Announces Strategic Alliance with United Concordia
10. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
11. Rigel Announces Fourth Quarter and Year End 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
Breaking Medicine News(10 mins):